SCHEMBL6495591

SCHEMBL6495591

C=CC(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OCCCN1CCCCC1C(=O)OCC

nearest known ligand 0.69

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.69
ERBB2 P04626 2/20 0.67
KDR P35968 7/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6496113 0.98 EGFR (0.70) EGFRERBB2KDR
SCHEMBL1418433 0.85 EGFR (0.52) EGFRERBB2
SCHEMBL6500373 0.85 EGFR (0.52) EGFRERBB2
SCHEMBL1417945 0.85 EGFR (0.83) EGFRERBB2KDR
SCHEMBL1418247 0.85 EGFR (0.83) EGFRERBB2KDR
SCHEMBL4231542 0.84 KDR (0.60) EGFRERBB2KDR
SCHEMBL4226680 0.84 KDR (0.60) EGFRERBB2KDR
SCHEMBL1419134 0.83 EGFR (0.83) EGFRERBB2KDR
SCHEMBL1417881 0.83 EGFR (0.62) EGFRERBB2
SCHEMBL1417882 0.83 EGFR (0.62) EGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6972288-B1 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-12-06 US disclosed